Medical device industry opposes draft Drugs, Medical Devices and Cosmetics Bill, 2026

Medical device companies, patient safety groups and healthcare providers have opposed the draft Bill, arguing that medical devices are fundamentally different from pharmaceuticals and require a distinct regulatory framework. Stakeholders have warned that treating devices like medicines could increase compliance burdens and adversely affect manufacturing, innovation and access to advanced technologies.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.